1 Market Overview
1.1 Neurological Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Alzheimers disease (AD)
1.2.2 Multiple sclerosis (MS)
1.2.3 Parkinsons disease (PD)
1.2.4 Autism spectrum disorder (ASD)
1.3 Market Analysis by Application
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Diagnostic and research laboratories
1.4 Market Analysis by Region
1.4.1 United States Market States and Outlook (2015-2028)
1.4.2 Europe Market States and Outlook (2015-2028)
1.4.3 China Market States and Outlook (2015-2028)
1.4.4 Japan Market States and Outlook (2015-2028)
1.4.5 Southeast Asia Market States and Outlook (2015-2028)
1.4.6 India Market States and Outlook (2015-2028)
1.4.7 Brazil Market States and Outlook (2015-2028)
1.4.8 GCC Countries Market States and Outlook (2015-2028)
1.5 Market Dynamics and Development
1.5.1 Merger, Acquisition and New Investment
1.5.2 Market SWOT Analysis
1.5.3 Drivers
1.5.4 Limitations
1.5.5 Opportunities and Development Trends
1.6 Global Neurological Biomarkers Market Size Analysis from 2015 to 2028
1.6.1 Global Neurological Biomarkers Market Size Analysis from 2015 to 2028 by Consumption Volume
1.6.2 Global Neurological Biomarkers Market Size Analysis from 2015 to 2028 by Value
1.6.3 Global Neurological Biomarkers Price Trends Analysis from 2015 to 2028
2 Global Neurological Biomarkers Competition by Types, Applications, and Top Regions and Countries
2.1 Global Neurological Biomarkers (Volume and Value) by Type
2.1.1 Global Neurological Biomarkers Consumption and Market Share by Type (2015-2020)
2.1.2 Global Neurological Biomarkers Revenue and Market Share by Type (2015-2020)
2.2 Global Neurological Biomarkers (Volume and Value) by Application
2.2.1 Global Neurological Biomarkers Consumption and Market Share by Application (2015-2020)
2.2.2 Global Neurological Biomarkers Revenue and Market Share by Application (2015-2020)
2.3 Global Neurological Biomarkers (Volume and Value) by Region
2.3.1 Global Neurological Biomarkers Consumption and Market Share by Region (2015-2020)
2.3.2 Global Neurological Biomarkers Revenue and Market Share by Region (2015-2020)
3 United States Neurological Biomarkers Market Analysis
3.1 United States Neurological Biomarkers Consumption and Value Analysis
3.2 United States Neurological Biomarkers Consumption Volume by Type
3.3 United States Neurological Biomarkers Consumption Structure by Application
4 Europe Neurological Biomarkers Market Analysis
4.1 Europe Neurological Biomarkers Consumption and Value Analysis
4.2 Europe Neurological Biomarkers Consumption Volume by Type
4.3 Europe Neurological Biomarkers Consumption Structure by Application
4.4 Europe Neurological Biomarkers Consumption by Top Countries
4.4.1 Germany Neurological Biomarkers Consumption Volume from 2015 to 2020
4.4.2 UK Neurological Biomarkers Consumption Volume from 2015 to 2020
4.4.3 France Neurological Biomarkers Consumption Volume from 2015 to 2020
4.4.4 Italy Neurological Biomarkers Consumption Volume from 2015 to 2020
4.4.5 Spain Neurological Biomarkers Consumption Volume from 2015 to 2020
4.4.6 Poland Neurological Biomarkers Consumption Volume from 2015 to 2020
4.4.7 Russia Neurological Biomarkers Consumption Volume from 2015 to 2020
5 China Neurological Biomarkers Market Analysis
5.1 China Neurological Biomarkers Consumption and Value Analysis
5.2 China Neurological Biomarkers Consumption Volume by Type
5.3 China Neurological Biomarkers Consumption Structure by Application
6 Japan Neurological Biomarkers Market Analysis
6.1 Japan Neurological Biomarkers Consumption and Value Analysis
6.2 Japan Neurological Biomarkers Consumption Volume by Type
6.3 Japan Neurological Biomarkers Consumption Structure by Application
7 Southeast Asia Neurological Biomarkers Market Analysis
7.1 Southeast Asia Neurological Biomarkers Consumption and Value Analysis
7.2 Southeast Asia Neurological Biomarkers Consumption Volume by Type
7.3 Southeast Asia Neurological Biomarkers Consumption Structure by Application
7.4 Southeast Asia Neurological Biomarkers Consumption by Top Countries
7.4.1 Indonesia Neurological Biomarkers Consumption Volume from 2015 to 2020
7.4.2 Thailand Neurological Biomarkers Consumption Volume from 2015 to 2020
7.4.3 Philippines Neurological Biomarkers Consumption Volume from 2015 to 2020
7.4.4 Malaysia Neurological Biomarkers Consumption Volume from 2015 to 2020
7.4.5 Singapore Neurological Biomarkers Consumption Volume from 2015 to 2020
7.4.6 Vietnam Neurological Biomarkers Consumption Volume from 2015 to 2020
8 India Neurological Biomarkers Market Analysis
8.1 India Neurological Biomarkers Consumption and Value Analysis
8.2 India Neurological Biomarkers Consumption Volume by Type
8.3 India Neurological Biomarkers Consumption Structure by Application
9 Brazil Neurological Biomarkers Market Analysis
9.1 Brazil Neurological Biomarkers Consumption and Value Analysis
9.2 Brazil Neurological Biomarkers Consumption Volume by Type
9.3 Brazil Neurological Biomarkers Consumption Structure by Application
10 GCC Countries Neurological Biomarkers Market Analysis
10.1 GCC Countries Neurological Biomarkers Consumption and Value Analysis
10.2 GCC Countries Neurological Biomarkers Consumption Volume by Type
10.3 GCC Countries Neurological Biomarkers Consumption Structure by Application
10.4 GCC Countries Neurological Biomarkers Consumption Volume by Major Countries
10.4.1 Saudi Arabia Neurological Biomarkers Consumption Volume from 2015 to 2020
10.4.2 United Arab Emirates Neurological Biomarkers Consumption Volume from 2015 to 2020
10.4.3 Qatar Neurological Biomarkers Consumption Volume from 2015 to 2020
10.4.4 Bahrain Neurological Biomarkers Consumption Volume from 2015 to 2020
11 Manufacturers Profiles
11.1 Cisbio Bioassays
11.1.1 Business Overview
11.1.2 Products Analysis
11.1.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.1.4 Cisbio Bioassays Neurological Biomarkers Sales by Region
11.2 Aepodia
11.2.1 Business Overview
11.2.2 Products Analysis
11.2.3 Aepodia Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.2.4 Aepodia Neurological Biomarkers Sales by Region
11.3 Thermo Fisher Scientific
11.3.1 Business Overview
11.3.2 Products Analysis
11.3.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.3.4 Thermo Fisher Scientific Neurological Biomarkers Sales by Region
11.4 QIAGEN
11.4.1 Business Overview
11.4.2 Products Analysis
11.4.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.4.4 QIAGEN Neurological Biomarkers Sales by Region
11.5 AbaStar MDx
11.5.1 Business Overview
11.5.2 Products Analysis
11.5.3 AbaStar MDx Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.5.4 AbaStar MDx Neurological Biomarkers Sales by Region
11.6 Proteome Sciences
11.6.1 Business Overview
11.6.2 Products Analysis
11.6.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.6.4 Proteome Sciences Neurological Biomarkers Sales by Region
11.7 Quanterix
11.7.1 Business Overview
11.7.2 Products Analysis
11.7.3 Quanterix Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.7.4 Quanterix Neurological Biomarkers Sales by Region
11.8 Myriad RBM
11.8.1 Business Overview
11.8.2 Products Analysis
11.8.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.8.4 Myriad RBM Neurological Biomarkers Sales by Region
11.9 Acumen Pharmaceuticals
11.9.1 Business Overview
11.9.2 Products Analysis
11.9.3 Acumen Pharmaceuticals Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.9.4 Acumen Pharmaceuticals Neurological Biomarkers Sales by Region
11.10 ImmunArray
11.10.1 Business Overview
11.10.2 Products Analysis
11.10.3 ImmunArray Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.10.4 ImmunArray Neurological Biomarkers Sales by Region
11.11 Athena Diagnostics
11.11.1 Business Overview
11.11.2 Products Analysis
11.11.3 Athena Diagnostics Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.11.4 Athena Diagnostics Neurological Biomarkers Sales by Region
11.12 Abiant
11.12.1 Business Overview
11.12.2 Products Analysis
11.12.3 Abiant Neurological Biomarkers Sales, Price, Revenue, Gross Margin
11.12.4 Abiant Neurological Biomarkers Sales by Region
13 Global Neurological Biomarkers Market Forecast (2020-2028)
13.1 Global Neurological Biomarkers Consumption Volume, Revenue and Price Forecast (2020-2028)
13.1.1 Global Neurological Biomarkers Consumption Volume and Growth Rate Forecast (2020-2028)
13.1.2 Global Neurological Biomarkers Value and Growth Rate Forecast (2020-2028)
13.1.3 Global Neurological Biomarkers Price and Trend Forecast (2020-2028)
13.2 Global Neurological Biomarkers Consumption Volume, Value and Growth Rate Forecast by Region (2020-2028)
13.2.1 Global Neurological Biomarkers Consumption Volume and Growth Rate Forecast by Region (2020-2028)
13.2.2 Global Neurological Biomarkers Value and Growth Rate Forecast by Region (2020-2028)
13.3 Global Neurological Biomarkers Consumption Volume, Revenue and Price Forecast by Type (2020-2028)
13.3.1 Global Neurological Biomarkers Consumption Forecast by Type (2020-2028)
13.3.2 Global Neurological Biomarkers Revenue Forecast by Type (2020-2028)
13.3.3 Global Neurological Biomarkers Price Forecast by Type (2020-2028)
13.4 Global Neurological Biomarkers Consumption Volume Forecast by Application (2020-2028)
14 Research Conclusions
15 Appendix
15.1 Methodology
15.2 Research Data Source
